Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Tigecycline for the Treatment of Infectious Diseases

NCT04937894 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT04937894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04937894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Tigecycline for the Treatment of Infectious Diseases
Lead sponsor
Shandong University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2021
Completion date
December 1, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infectious disease